Mechanisms of antiprostate cancer by gum mastic:: NF-κB signal as target

被引:45
作者
He, Mei-lan [1 ]
Li, Ang
Xu, Chun-su
Wang, Shun-li
Zhang, Meng-jie
Gu, Hua
Yang, Yao-qin
Tao, Hui-hong
机构
[1] Tongji Univ, Life Sci & Technol Sch, Inst Canc Res, Shanghai 200092, Peoples R China
[2] Tongji Univ, Sch Med, Cellular Morphol Ctr, Shanghai 200092, Peoples R China
关键词
gum mastic; prostate cancer; NF-kappa B signal;
D O I
10.1111/j.1745-7254.2007.00536.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To study the effect of gum mastic, a natural resin, on the proliferation of androgen-independent prostate cancer PC-3 cells, and further investigate the mechanisms involved in this regulatory system, taking nuclear factor kappa B (NF-kappa B) signal as the target. Methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and a flow cytometer were used to detect the effect of gum mastic on the proliferation of PC-3 cells. Then, reporter gene assay, RT-PCR, and Western blotting were carried out to study the effects of gum mastic on the NF-kappa B protein level and the NF-kappa B signal pathway. The expression of genes involved in the NF-kappa B signal pathway, including cyclin D1, inhibitors of kappa BS (I kappa B alpha), and phosphorylated Akt (p-AKT), were measured. In addition, transient transfection assays with the 5 x NF-kappa B consensus sequence promoter was also used to test the effects of gum mastic. Results: Gum mastic inhibited PC-3 cell growth and blocked the PC-3 cell cycle in the G1 phase. Gum mastic also suppressed NF-kappa B activity in the PC-3 cells. The expression of cyclin D1, a crucial cell cycle regulator and an NF-kappa B downstream target gene, was reduced as well. Moreover, gum mastic decreased the p-AKT protein level and increased the I kappa B alpha protein level. Conclusion: Gum mastic inhibited the proliferation and blocked the cell cycle progression in PC-3 cells by suppressing NF-kappa B activity and the NF-kappa B signal pathway.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 34 条
[1]   A DOUBLE-BLIND CONTROLLED CLINICAL-TRIAL OF MASTIC AND PLACEBO IN THE TREATMENT OF DUODENAL-ULCER [J].
ALHABBAL, MJ ;
ALHABBAL, Z ;
HUWEZ, FU .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (05) :541-544
[2]   EVALUATION OF MASTIC, A CRUDE DRUG OBTAINED FROM PISTACIA-LENTISCUS FOR GASTRIC AND DUODENAL ANTIULCER ACTIVITY [J].
ALSAID, MS ;
AGEEL, AM ;
PARMAR, NS ;
TARIQ, M .
JOURNAL OF ETHNOPHARMACOLOGY, 1986, 15 (03) :271-278
[3]   Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation [J].
Andrikopoulos, NK ;
Kaliora, AC ;
Assimopoulou, AN ;
Papapeorgiou, VP .
PHYTOTHERAPY RESEARCH, 2003, 17 (05) :501-507
[4]  
Balan KV, 2005, IN VIVO, V19, P93
[5]   Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription [J].
Buss, H ;
Dörrie, A ;
Schmitz, ML ;
Hoffmann, E ;
Resch, K ;
Kracht, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55633-55643
[6]  
Chen HF, 2004, RARE METAL MAT ENG, V33, P9
[7]  
CHRISTOPHER S, 2004, CLIN CANCER RES, V10, P5501
[8]   Mechanisms of androgen-refractory prostate cancer. [J].
Debes, JD ;
Tindall, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1488-1490
[9]  
DENIS C, 1999, MOL CELL BIOL, V19, P5785
[10]  
Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO